Craig Hackett
Impact in
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Oncology top 10%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in ⓘ
- Co-authors
- Ferenc Boldog (5 shared papers)Henri S. Lichenstein (4 shared papers)Michael Jeffers (2 shared papers)James W.A. Ritchie (1 shared paper)Maxwell Sehested (2 shared papers)Laura S. Collins (1 shared paper)Anthony Tumber (1 shared paper)Sampath Kumar (1 shared paper)
- Journals
- Blood (1 paper)Cancer Biology & Therapy (1 paper)Clinical Cancer Research (1 paper)Biochemical Journal (1 paper)The Lancet Neurology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Craig Hackett
11 papers receiving 910 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Biology 674
- Oncology 239
- Physiology 32
- Cellular and Molecular Neuroscience 94
- Immunology 98
Countries citing papers authored by Craig Hackett
This map shows the geographic impact of Craig Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Hackett more than expected).
Fields of papers citing papers by Craig Hackett
This network shows the impact of papers produced by Craig Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Hackett. The network helps show where Craig Hackett may publish in the future.
Co-authors
The 25 scholars most cited alongside Craig Hackett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors Hit paper breakdown → | 2007 | 599 |
| 2 | 2006 | 137 | |
| 3 | 2005 | 63 | |
| 4 | 1991 | 45 | |
| 5 | 2023 | 29 | |
| 6 | 2006 | 20 | |
| 7 | 2002 | 16 | |
| 8 | 2016 | 11 | |
| 9 | 2016 | 6 | |
| 10 | 2025 | 1 | |
| 11 | 2006 | 1 |
About Craig Hackett
Craig Hackett is a scholar working on Pathology and Forensic Medicine, Immunology and Allergy, Dermatology, Oncology and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 928 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (2 papers), Protein Degradation and Inhibitors (2 papers), HER2/EGFR in Cancer Research (2 papers), Peptidase Inhibition and Analysis (1 paper), Nerve Injury and Rehabilitation (1 paper), Nerve injury and regeneration (1 paper), Signaling Pathways in Disease (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Molecular Biology (674 citations), Oncology (239 citations), Physiology (32 citations), Cellular and Molecular Neuroscience (94 citations) and Immunology (98 citations). Craig Hackett has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Ferenc Boldog, Henri S. Lichenstein, Michael Jeffers, James W.A. Ritchie, Maxwell Sehested, Laura S. Collins, Anthony Tumber, Sampath Kumar, Xiaozhong Qian and Nagma Khan. Their work appears in journals such as Blood, Cancer Biology & Therapy, Clinical Cancer Research, Biochemical Journal and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.